Manhattan Scientifics, Inc. (MHTX)

Manhattan Scientifics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0	0.05	0.05	0.05	0.1
Revenue Growth (YoY)	-	0%	0%	-48.45%	-
Cost of Revenue	0	0	0	0	0
Gross Profit	-0	0.05	0.05	0.05	0.1
Selling, General & Admin	0.69	0.72	0.73	0.71	1.11
Research & Development	0.01	0.01	0.01	0.01	0.01
Operating Expenses	0.7	0.73	0.74	0.73	1.12
Operating Income	-0.7	-0.68	-0.69	-0.68	-1.03
Interest Income	0	0.02	0.03	0.03	0.01
Interest Expense	0	0.02	0.03	0.03	0.01
Other Expense / Income	0.46	2.05	2.95	-5.01	0.2
Pretax Income	-1.17	-2.73	-3.64	4.31	-1.22
Income Tax	0	2.03	0.03	0.03	0.01
Net Income	-1.17	-4.76	-3.67	4.31	-1.23
Shares Outstanding (Basic)	559	559	559	558	549
Shares Outstanding (Diluted)	559	559	559	593	549
Shares Change	-	-	-5.69%	7.95%	2.92%
EPS (Basic)	-0.00	-0.01	-0.01	0.01	-0.00
EPS (Diluted)	-0.00	-0.01	-0.01	0.01	-0.00
Free Cash Flow	-0.19	-0.35	-0.42	-0.39	-0.32
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00
Gross Margin	-	94.00%	96.00%	100.00%	100.00%
Operating Margin	-	-1358.00%	-1374.00%	-1350.00%	-1056.70%
Profit Margin	-	-9520.00%	-7330.00%	8628.00%	-1264.95%
Free Cash Flow Margin	-	-698.00%	-842.00%	-784.00%	-325.77%
Effective Tax Rate	-	-	-	0.58%	-
EBITDA	-0.7	-0.68	-0.69	-0.67	-1.02
EBITDA Margin	-	-1352.00%	-1370.00%	-1346.00%	-1054.64%
Depreciation & Amortization	0	0	0	0	0
EBIT	-0.7	-0.68	-0.69	-0.68	-1.03
EBIT Margin	-	-1358.00%	-1374.00%	-1350.00%	-1056.70%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.